Pep19 may alter fat distribution without weight loss - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Pep19 may alter fat distribution without weight loss

  • By

  • Andrea Surnit

  • November 17, 2026

  • 5 min

Share

  • 1

    In a 90-day randomized trial of 56 adults with obesity, 10-mg Pep19 reduced the android-to-gynoid fat ratio compared with placebo, whereas 5 mg did not.

  • 2

    Pep19 did not significantly change body weight, BMI, total fat mass, or lean mass compared with placebo.

  • 3

    The 10-mg dose reduced abdominal skinfold thickness and was associated with lower HbA1c and HOMA-IR; fasting glucose remained unchanged.

  • 4

    Lipid profiles, inflammatory biomarkers, and blood pressure did not differ significantly among groups, and no treatment-related toxicologic signals were identified.

  • 5

    The small sample, 90-day follow-up, and nonsignificant absolute-scale analysis of the primary endpoint limit interpretation; larger, longer trials are needed.

Original Source(s)

Related Content